The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

UCSF researchers showed that estrogen can turn on pain signals in the gut, offering new insights into conditions like ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

Addyi (flibanserin) was cleared a decade ago to treat low sex drive in women before menopause. A new FDA action allows ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

Male hypogonadism means your body isn’t making enough testosterone, the hormone that plays a role in drive, energy, and muscle strength. Primary hypogonadism starts … ...

Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...

U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido, saying the once-a-day pill can now be taken by women older than 65.

Wendy Wisner is a journalist and international board certified lactation consultant (IBCLC). She has written about all things pregnancy, maternal/child health, parenting, and general health and ...

Mississippi River levels are low this fall season—for the third year in a row. “The timing couldn’t be worse,” says Jon Davis, chief meteorologist at Everstream Analytics. “October is a critical month ...